We aimed to search for prophylactic treatment targeting multiple neuropathological changes before outward symptoms of AD become apparent because aggregation of Aβ and hyperphosphorylation of tau begin in the pre‐symptomatic stage that intervening AD as early as possible is deemed more effective and practical (Jack et al, 2010, 2013). The gene discussed is MAPT; the disease is Alzheimer disease.